LabPulse

Your resource for news about the clinical laboratory community! Check us out at

[LabPulse @LabPulse1]

Don't miss out on our free whitepaper resource: Conventional versus Convenience: Clinician Collected or At-Home Collected Testing for Sexually Transmitted Infections!

Download the whitepaper here: https://t.co/a8nAHIuGJf

[LabPulse @LabPulse1]

The U.S. National Institutes of Health (NIH) has named Dr. Jeanne Marrazzo as Dr. Anthony Fauci’s full-time replacement as the head of the National Institute of Allergy and Infectious Diseases (NIAID).
https://t.co/Psf1JEgRaH

[LabPulse @LabPulse1]

Molecular diagnostics company Co-Diagnostics is to receive over $2 million from the Bill & Melinda Gates Foundation toward completion of tuberculosis (TB) and human papillomavirus (HPV) tests for the company's Co-Dx PCR Home platform.
https://t.co/PyuhCbD5yn

[LabPulse @LabPulse1]

Illumina has struck a deal to make Pillar Biosciences’ oncology assets commercially available globally as part of its own portfolio.
https://t.co/UnTOF4kK2y

[LabPulse @LabPulse1]

Cumulus Neuroscience is joining with two U.K. universities -- Bath and Bristol -- on the development of a test for cognition with potential as an early diagnosis tool in Alzheimer’s dementia.
https://t.co/UfPexptOsd

[LabPulse @LabPulse1]

The U.S. Food and Drug Administration (FDA) has started a one-year pilot program to help reduce the risks associated with laboratory developed oncology tests.
https://t.co/wLCGsVZfJE

[GenomicMD @GenomicMD]

ApoB tests may reveal risk of heart disease missed by #cholesterol tests
https://t.co/XpPnWG6zSO via @LabPulse1 #cardiovascular

[Nature Biotechnology @NatureBiotech]

New scanning method creates whole-body “atlases” of biological systems #NBTintheNews via @LabPulse1 https://t.co/b7o9SywMRz

[LabPulse @LabPulse1]

The Association for Molecular Pathology (AMP) and other bodies have published recommendations on the inclusion of additional alleles in clinical pharmacogenomic (PGx) genotyping assays.
https://t.co/Gl3sVi5csG

[LabPulse @LabPulse1]

The Association for Molecular Pathology (AMP) and other bodies have published recommendations on the inclusion of additional alleles in clinical pharmacogenomic (PGx) genotyping assays.

https://t.co/Gl3sVi5csG

[LabPulse @LabPulse1]

An analysis of 462 million lipid test results has shown mean total cholesterol levels exceed the target in seven of the 17 studied countries.

https://t.co/9uiu2R7b1c

[LabPulse @LabPulse1]

Whole genome sequencing (WGS) is better than a targeted test at identifying abnormalities responsible for genetic disorders in newborns and infants but also costs more and takes longer, according to a study published in JAMA. https://t.co/WG62ESxzoq

[LabPulse @LabPulse1]

Quest Diagnostics has launched its first consumer-initiated genetic test, Genetic Insights, which is available through its consumer site https://t.co/PQHOyk5yJ7.
https://t.co/Svmj4QtVTj

[LabPulse @LabPulse1]

Under the deal, DiamiR will apply the capabilities of JADBio’s Automated Machine Learning (AutoML) bioinformatics platform and services to its own microRNA platform. https://t.co/SBjmsgRs6V

[LabPulse @LabPulse1]

Through the analysis, the researchers identified 69 associations between CpGs and the prevalence of breast cancer, chronic kidney disease, ischemic heart disease, and type 2 diabetes. The majority of the associations had not previously been described. https://t.co/orhwlKatmc

[LabPulse @LabPulse1]

@SiemensHealth and @Unilabs entered an agreement valued at more than €200 million. Unilabs plans to adopt Siemens' testing equipment to continuously modernize its healthcare infrastructure and enhance lab operations. https://t.co/68H7kRNboD

[LabPulse @LabPulse1]

Labcorp will pay $19 million as part of a settlement with two whistleblowers who alleged that the firm facilitated kickbacks and violated the False Claims Act. https://t.co/qiohHqRHkj

[LabPulse @LabPulse1]

The FDA has granted an authorization for the LumiraDx SARS-CoV-2 & Flu A/B RNA Star Complete assay. The test allows for the differentiation of influenza A, influenza B, and SARS-CoV-2 infections within 20 minutes or less. @US_FDA @LumiraDx https://t.co/g9soPYDKmR

[LabPulse @LabPulse1]

The FDA granted clearance for the BioFire Spotfire Respiratory Panel. It became the first respiratory panel to test for SARS-CoV-2 that also received a CLIA waiver. https://t.co/OxgSfdIjsb @BioFireDX @US_FDA

[LabPulse @LabPulse1]

Long COVID, a post-infection inflammatory syndrome, is significantly impacting the workforce, according to a report published by the New York State Insurance Fund (NYSIF), the state���s largest worker compensation insurance fund. https://t.co/pn3FjpSpis